PH25733A - 5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders - Google Patents

5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders

Info

Publication number
PH25733A
PH25733A PH36230A PH36230A PH25733A PH 25733 A PH25733 A PH 25733A PH 36230 A PH36230 A PH 36230A PH 36230 A PH36230 A PH 36230A PH 25733 A PH25733 A PH 25733A
Authority
PH
Philippines
Prior art keywords
triazol
aryl
ones
treatment
neurogenerative disorders
Prior art date
Application number
PH36230A
Inventor
Francis P Miller
Stephen Sorensen
John M Kane
Original Assignee
Merrel Dow Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrel Dow Pharmaceuticals filed Critical Merrel Dow Pharmaceuticals
Publication of PH25733A publication Critical patent/PH25733A/en

Links

PH36230A 1987-10-16 1987-12-15 5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders PH25733A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10700187A 1987-10-16 1987-10-16

Publications (1)

Publication Number Publication Date
PH25733A true PH25733A (en) 1991-10-18

Family

ID=22314340

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36230A PH25733A (en) 1987-10-16 1987-12-15 5-aryl-3h-1,2,4-triazol-3-ones, their use in the treatment of neurogenerative disorders

Country Status (2)

Country Link
PH (1) PH25733A (en)
ZA (1) ZA879420B (en)

Also Published As

Publication number Publication date
ZA879420B (en) 1988-07-27

Similar Documents

Publication Publication Date Title
GB2207055B (en) Apparatus for use in the treatment of spinal disorders
EP0205579A4 (en) Methods and compositions useful in the diagnosis and treatment of autoimmune diseases.
ZA887889B (en) Process for the manufacture of 1,1,1-trifluorodichloroethylene and 1,1,1,2-tetrafluorochloroethylene
EP0243968A3 (en) Diacetylrhein salts and their therapeutical use in the treatment of arthritis
EP0275668A3 (en) Use of ketone derivatives in the treatment of cognitive disorders
EP0432856A3 (en) Use of rolipram in the treatment of dementia
EP0437026A3 (en) Use of tandospirone in the treatment of depression
ZA935154B (en) Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions
GB8708049D0 (en) Dental treatment
ZA908490B (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
EP0271127A3 (en) Use of guaifenesin in the treatment of urologic disorders
GB8715914D0 (en) Treatment of cerabral disorders
ZA887364B (en) Ovulation treatment
ZA879420B (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders
ZA87873B (en) Substituted diazapines and derivatives thereof useful in the treatment of cardiovascular disorders
JPS6422876A (en) 8 alpha-acylaminoergoline, manufacture and medicine
EP0407016A3 (en) Use of benzodioxinopyrrole derivatives in the treatment of anxiety
ZA883253B (en) Improvements in the treatment of sand
ZA885484B (en) N-alkenoyl enamides,their preparation and the use thereof
Hung The sixteen Lohans of the Rakan-zusan-shu
SG4695G (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases
ZA876485B (en) 5-aminoethyloxazolidin-2-one derivatives,process for the preparation thereof and their therapeutic use
EP0269024A3 (en) Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
GB8719190D0 (en) Treatment
GB8726982D0 (en) Treatment